Results
1 -
10 of
11
(Click
here to explore results)
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 8 Design and Development of NS5B Polymerase Non‐nucleoside Inhibitors for the Treatment of Hepatitis C Virus Infection. Pierre L. Beaulieu
, 2013
, Pages 248-294
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- Macrocycles in Drug Discovery, Subject Index
, 2015
, Pages 487-499
- Sustainable Synthesis of Pharmaceuticals: Using Transition Metal Complexes as Catalysts, Chapter 9 Metal-catalysed Metathesis Reactions for Greener Synthon/Drug Synthesis. E. N. dos Santos, A. V. Granato, A. G. Santos
, 2018
, Pages 230-252
- Macrocycles in Drug Discovery, Contents
, 2015
, Pages P013-P020
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs. Lianhong Xu, Manoj C. Desai
, 2013
, Pages 451-481
- Macrocycles in Drug Discovery, CHAPTER 7 Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets. Wieslaw M. Kazmierski, Richard L. Jarvest, Jacob J. Plattner, Xianfeng Li
, 2015
, Pages 235-282
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 7 HCV NS3/4a Protease Inhibitors: Simeprevir (TMC‐435350), Vaniprevir (MK‐7009) and MK‐5172. John A. McCauley, Michael T. Rudd, Nigel J. Liverton
, 2013
, Pages 189-247
- Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 10 Development Programs for Oral Fixed Dose Combination Products. Patrick J. Crowley, Sharon M. Maglennon, Luigi G. Martini, David Templeton
, 2022
, Pages 259-286